Trans-2-enoyl-CoA reductase, mitochondrial
AltitudeomicsDB
Protein Official symbol |
MECR |
Aliases |
MECR NBRF1 CGI-63 |
Chromosomal Location |
1 |
Length |
373 |
Uniprot ID |
Q9BV79 |
EC number |
1.3.1.104 |
Protein family Information(Pfam) |
PF08240;PF00107; |
PDB id |
1ZSY;2VCY; |
InterPro ID |
IPR013149;IPR013154;IPR011032;IPR036291;IPR020843; |
dbSNP |
rs1128400 rs11544658 rs762913101 rs34835902 rs145192716 rs759218713 |
AltitudeomicsDB
Protein 1 |
Protein 2 |
Combine Score |
HADHA |
HADHB |
0.999 |
HADHA |
ACAA2 |
0.979 |
ECHS1 |
ACAA2 |
0.932 |
HADHA |
ECHS1 |
0.931 |
HADHB |
MECR |
0.93 |
ACAA2 |
MECR |
0.929 |
HADHB |
ACAA2 |
0.925 |
ECHS1 |
MECR |
0.916 |
HADHA |
MECR |
0.914 |
PPT1 |
MECR |
0.905 |
PPT2 |
MECR |
0.903 |
Association with High Altitude
Protein Official symbol |
Source Organism |
Tissue of Expression |
Level of hypoxia |
Altitude |
Duration of experiment |
Level of expression |
Fold change |
Experiment details |
geographical location |
ethnicity of the patients |
Control group |
Control (Fold change) |
Reference (PMID) |
MECR |
Bird |
Cardiac muscle |
- |
4000 m |
Native |
downregulated |
-2.58 |
Sequencing |
Central Asia |
L. dichrous (Bird) |
1 |
L. dichrous vs. Po. Palustris |
31127049 |
Association with TF
TF |
TF Entrez |
Gene |
Gene Entrez |
Type |
PMID |
Database |
Association with miRNA
miRTarBase ID |
miRNA |
Species (miRNA) |
Protein Official Symbol |
Human Entrez ID |
Species (Target Gene) |
Experiments |
Support Type |
References (PMID) |
MIRT020488 |
hsa-miR-155-5p |
Homo sapiens |
MECR |
51102 |
Homo sapiens |
Proteomics |
Functional MTI (Weak) |
18668040 |
MIRT023488 |
hsa-miR-1-3p |
Homo sapiens |
MECR |
51102 |
Homo sapiens |
Proteomics |
Functional MTI (Weak) |
18668040 |
MIRT038990 |
hsa-let-7f-1-3p |
Homo sapiens |
MECR |
51102 |
Homo sapiens |
CLASH |
Functional MTI (Weak) |
23622248 |
MIRT043378 |
hsa-miR-331-3p |
Homo sapiens |
MECR |
51102 |
Homo sapiens |
CLASH |
Functional MTI (Weak) |
23622248 |
Gene Ontology
ID |
GO ID |
GO Term |
GO Type |
51102 |
GO:0019166 |
GDP binding |
GOTERM_MF_DIRECT |
51102 |
GO:0006631 |
fatty acid metabolic process |
GOTERM_BP_DIRECT |
51102 |
GO:0005634 |
nucleus |
GOTERM_CC_DIRECT |
51102 |
GO:0016491 |
oxidoreductase activity |
GOTERM_MF_DIRECT |
51102 |
GO:0055114 |
oxidation-reduction process |
GOTERM_BP_DIRECT |
51102 |
GO:0005739 |
mitochondrion |
GOTERM_CC_DIRECT |
51102 |
GO:0006633 |
fatty acid biosynthetic process |
GOTERM_BP_DIRECT |
51102 |
GO:0008270 |
zinc ion binding |
GOTERM_MF_DIRECT |
Pathways
Human Entrez ID |
KEGG ID |
KEGG Term |
51102 |
hsa00062 |
Fatty acid elongation |
51102 |
hsa01100 |
Metabolic pathways |
51102 |
hsa01212 |
Fatty acid metabolism |
Association with Disease
Protein Official Symbol |
Human Entrez ID |
Disease Name |
Disease Id |
Disease Semantic Type |
Semantic score |
DSI |
DPI |
Disease Type |
MECR |
51102 |
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES |
C4310634 |
Disease or Syndrome |
0.6 |
0.735 |
0.207 |
disease |
MECR |
51102 |
Intellectual Disability |
C3714756 |
Mental or Behavioral Dysfunction |
0.3 |
0.735 |
0.207 |
group |
MECR |
51102 |
Mitochondrial Diseases |
C0751651 |
Disease or Syndrome |
0.3 |
0.735 |
0.207 |
group |
Association with Drug
Protein Official Symbol |
Human Entrez ID |
drug_claim_primary_name |
drug_name |
drug_chembl_id |
interaction_types |